Breaking News, Promotions & Moves

AbbVie Appoints R&D EVP

Severino to drive pipeline advancement

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Michael Severino, M.D. has been named executive vice president, R&D and chief scientific officer at AbbVie. Dr. Severino will be responsible for leading the R&D, Medical Affairs and Regulatory Affairs organizations. He brings expertise from his career spanning genomics and development within the biotech industry.   Dr. Severino most recently served as senior vice president and chief medical officer at Amgen, leading the clinical development strategy across inflammation/immunology, neuros...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters